Stockreport

Coherus down 3% on Enbrel patent ruling [Seeking Alpha]

Coherus BioSciences, Inc.  (CHRS) 
Last coherus biosciences, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com
PDF Coherus BioSciences ( CHRS ) slips in average volume in apparent reaction to a district court ruling on two Enbrel patents favorable to Amgen. Novartis unit [Read more]